A Detail View of Single-Use Equipment Opportunities - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

A Detail View of Single-Use Equipment Opportunities
The authors propose increased use of single-use technologies in biopharmaceutical manufacturing to achieve operational excellence without compromising product quality.


Pharmaceutical Technology
Volume 34, pp. s16-s20

Technology-integration improvements

The "single-use" concept came loaded with huge expectations of finding new solutions to address the needs of the changing biopharmaceutical industry. Suppliers of single-use equipment have had difficulty living up to these expectations thus far, partly because the expectations were not properly defined and partly due to intellectual property (IP) and supply-chain issues.


Figure 3: Water-consumption percentage differences: Stainless steel versus single-use equipment (Data from Ref. 9).
In a hard-piped manufacturing process, the bioprocessing flow path is only qualified once. With single-use technology, a new flow path might be supplied various times, especially in multipurpose scenarios, and the qualification of the new flow's components is often in the hands of the supplier. The supplier is urged to provide disposable flow paths using the same components and properties for years to come.

To meet this request, however, the supplier must own all of the critical pieces of a particular assembly. For this reason, many suppliers are aligning with, or acquiring, component suppliers and IP owners. Unfortunately, a lack of standards and competition in this arena has promoted a vast array of equipment items, assemblies, and validation-procedure differences. These varieties, marketing-driven product and validation claims cause more insecurities and questions, than solid standardized solutions.

Promising new development, in the form of single-use unit operations, is moving away from isolated technical solutions and toward new, highly-integrated concepts. End-users of disposable bags for media initiated this trend in an effort to move from a fixed process to a single-use process that includes mixing, filtration, temperature, recipe, and level control.

The integration of disposable sensors helped develop fully-disposable, cell-culture systems and opened the door for single-use applications for most of the unit operations within a manufacturing process. New approaches are supplying single-use technology platforms along the typical manufacturing process.

The application know-how determines the design of those platforms, but standardization of components such as tubing and connectors, ensures interconnectivity at the same time. These concepts allow a clean and streamlined process with a unified automation, control, and validation concept and, finally, a high level of operational excellence and security.

The single-use approach demands the highest level of technology integration possible. However, the economic and operational advantages of the disposable option apply mostly to Green Field Facilities (i.e., facilities planned from scratch) with high-value, low-volume products and might not be an option for existing manufacturing processes. This restriction to new facility design is a purely economical one as most of the capital investments within existing processes are made and the equipment is written off. Nevertheless, the flexibility of single-use manufacturing philosophy is attractive for expansion projects within existing facilities. In addition, so-called "hybrid" systems merge the best out of both worlds by integrating single-use unit operations such as buffer and media-hold steps, into existing production facilities.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here